What happens when you take biotin with troponin test?
Biotin, also known as vitamin B7 or vitamin H, is a water-soluble vitamin found in many over-the-counter supplements marketed for hair, skin, and nail health. Doses in these products commonly range from 5,000 to 10,000 micrograms (mcg), which is hundreds of times the 30 mcg daily adequate intake set by the National Institutes of Health. When you swallow biotin at these high doses, blood levels rise far above what diet alone produces, and they stay elevated for hours to days depending on kidney function.
Cardiac troponin (troponin I or troponin T) is the gold-standard blood test for diagnosing a heart attack. Most modern hospital and laboratory troponin assays use a clever chemistry trick called the biotin-streptavidin system: an antibody is tagged with biotin, and that biotin is then captured by streptavidin molecules fixed to a magnetic bead or plate. If the patient already has high circulating biotin from a supplement, that excess biotin competes with the assay's own biotin tag for the streptavidin binding sites. The result is a falsely low troponin reading, sometimes reported as undetectable even when the patient is in the middle of an actual heart attack.
The U.S. Food and Drug Administration issued a Safety Communication on this issue in 2017 and reinforced the warning in 2019 after receiving a report of a patient who died because biotin interference produced falsely normal troponin results, and the heart attack was not diagnosed in time.
Why is this important?
Troponin is not a screening test. It is ordered when a clinician suspects a serious problem, most often acute myocardial infarction, but also pulmonary embolism, myocarditis, and severe sepsis. The treatment decisions that follow a troponin result are immediate and high-stakes: whether to give blood thinners, whether to take the patient to the cardiac catheterization lab, whether to admit to a coronary care unit. A falsely low troponin can send a patient with a real heart attack home from the emergency department.
The interference is dose-dependent. Studies summarized by the FDA and the Association for Diagnostic and Laboratory Medicine show that biotin doses of 5 mg (5,000 mcg) and above can affect many troponin assays, and very high doses used in neurology (300 mg daily, sometimes prescribed off-label for multiple sclerosis) can disrupt almost every commercial assay on the market. The interference is not always recognized because biotin is rarely on the radar of emergency physicians and may not appear on a patient's medication list if it is sold as a beauty supplement.
Biotin is also widely found in products that consumers do not think of as biotin: prenatal vitamins, hair-growth gummies, energy supplements, and combination B-complex tablets. Many people take more than one product, stacking the dose without realizing it.
What should you do?
If you take any biotin-containing supplement, treat a planned blood draw as a reason to pause. The general guidance from clinical chemistry experts is to stop biotin at least 72 hours before testing for most over-the-counter doses, and longer (up to a week) for doses above 10 mg per day or in people with kidney impairment, where biotin clears more slowly.
If you have to go to the emergency room with chest pain, shortness of breath, or other symptoms that might trigger a troponin test, tell the triage nurse and the physician immediately that you take biotin, what dose, and when you last took it. Do not skip this even if you only take a small amount. The lab can switch to an assay that is not affected by biotin, or the clinician can repeat the troponin after biotin has cleared.
People with chronic conditions that involve repeated troponin checks, such as recurrent chest pain syndromes, advanced heart failure, or kidney disease on dialysis, should consider whether the supplement is worth the diagnostic risk. The strongest evidence for biotin supplementation is in rare inherited metabolic disorders. There is little high-quality evidence that biotin meaningfully improves hair, skin, or nail outcomes in people who are not deficient.
Which specific products are affected?
Standalone biotin tablets and capsules at 1,000 mcg, 5,000 mcg, and 10,000 mcg strengths are the highest-risk products. Hair, skin, and nail combination supplements from brands like Nature's Bounty, Sports Research, and many gummy vitamin lines frequently contain 5,000 to 10,000 mcg of biotin per serving. Prenatal vitamins almost always contain biotin, though usually at lower doses (30 to 300 mcg). B-complex supplements typically contain 30 to 1,000 mcg. High-dose prescription or off-label biotin used in some neurology protocols can reach 300 mg per day, hundreds of times the doses sold over the counter.
On the lab side, troponin assays known to be susceptible to biotin interference include several widely used platforms from Roche (Elecsys), Beckman Coulter (Access), Siemens (Dimension and ADVIA Centaur), and Ortho-Clinical Diagnostics. The FDA does not maintain a single approved list, because manufacturers update their assays over time. Newer high-sensitivity troponin assays vary in their vulnerability. Ask the laboratory directly which assay they use and what their biotin tolerance threshold is.
The bottom line
Biotin is a common, low-cost supplement with a benign reputation, but at the doses sold in beauty products it can quietly sabotage one of the most important emergency blood tests in medicine. Stop biotin at least 72 hours before any blood draw that might include a troponin test, and always disclose biotin use in the emergency department. The FDA considers this interaction serious enough to have issued multiple safety communications, and a fatality has already been linked to it. The supplement is not worth a missed heart attack.